Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C11orf98 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CHTOP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ENSA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAPDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPA1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INTS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OCIAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP1S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
QRSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTMS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on